VARA (Virtual and Augmented Reality Applications in Rehabilitation): Motor Rehabilitation Protocol With GRAIL for Patients Affected by Hemiparesis
NCT ID: NCT04286997
Last Updated: 2021-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2018-09-13
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In particular, the specific goals will be:
* increase in walking symmetry and a better distribution among the time of stance and swing.
* Kinematics and Kinetics correction, with incentive of more corrected activation timing.
* Recruitment of the muscles most involved by the paresis, with the help of visual feedback.
* walking speed increase (but with the priority of the walking pattern)
* increase in the resistance
* Stregthening of the support reaction
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Rehabilitation in Patients With Acquired Brain Injury
NCT03402360
Robotic rEhabilitation sCenario fOr patieNts With NeglECT
NCT06890481
Virtual Reality and Robot Assisted Gait Training in Patients With Multiple Sclerosis
NCT02896179
Telerehabilitation in Disabled People: Proposal for Practical Intervention With Virtual Reality
NCT04402034
Upper Limb Task-Oriented Rehabilitation With Robotic Exoskeleton for Hemiparetic Stroke Patients
NCT03319992
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GRAIL population
patients are treated with 20 sessions of GRAIL rehabilitation, associated to 20 traditional physiotherapy sessions (1+1 a day, during a period of 30 days)
GRAIL population
each subjects included in the intervention group will receive 20 GRAIL sessions, aimed to the walking pattern improvement, associated with 20 traditional physiotherapy sessions, aimed to the stabilization of the trained competences
traditional population
subjects are treated with 40 sessions of traditional physiotherapy (2 a day, during a period of 30 days)
GRAIL population
each subjects included in the intervention group will receive 20 GRAIL sessions, aimed to the walking pattern improvement, associated with 20 traditional physiotherapy sessions, aimed to the stabilization of the trained competences
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GRAIL population
each subjects included in the intervention group will receive 20 GRAIL sessions, aimed to the walking pattern improvement, associated with 20 traditional physiotherapy sessions, aimed to the stabilization of the trained competences
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* recent (under 6 months) lower limbs surgery
* cognitive or emotional/relational obstacles to the therapy
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Eugenio Medea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS E.Medea
Bosisio Parini, Lecco, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
585
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.